Safety Study of Dabigatran in CADASIL "SONICA"


Phase 2 Results N/A

Summary of Purpose

This study is a Phase II, randomized, crossover trial designed to compare one fixed dose of dabigatran with open-label use of ASA in patients affected by CADASIL; the study is a safety trial, and the primary objective is to assess that dabigatran is not less safe than ASA in subjects with CADASIL.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 February 2014.

1 Jun 2011 16 May 2011 1 Jan 2015 1 Feb 2015 1 Dec 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Crossover Assignment